Kamala Harris says she’s pro-cannabis legalization. As was made apparent during the debate last night, her record says otherwise
In many respects, the final night of the second round of Democratic debates was a lot like the penultimate episode of Game of Thrones: somehow, it managed to be bloody and impossibly boring at the same time. The target of most of the candidates’ ire was former Vice President Joe Biden, currently the leading Democratic candidate in the polls, who took half-hearted hit after half-hearted hit with the unwavering, rictus-grinned composure of a crash test dummy.
But Biden wasn’t the only candidate to take a beating. In one particularly brutal moment, Sen. Tulsi Gabbard took aim at Sen. Kamala Harris, a former California attorney general who is also widely considered one of the leading candidates in the race, attacking Harris for her prosecutorial record and accusing her of blocking evidence that could have potentially freed a man from death row. Gabbard particularly zeroed in on Harris’s record on drug-related offenses: “She put over 1,500 people in jail for marijuana violations and then laughed about it when she was asked if she ever smoked marijuana,” Gabbard said, referring to an interview Harris gave to The Breakfast Club in which she joked about smoking pot in college. [Read More @ Rolling Stone]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
POSaBIT, the cannabis point-of-sale (POS) and payments software company, this morning announced its planned acquisition of MJ Platform (MJ Freeway), Leaf Data Systems, and Ample Organics from embattled software company…
New York marijuana regulators on Wednesday approved dozens of conditional adult-use dispensary licenses in a session during which members also discussed adopting bylaws for how the board runs meetings and makes decisions.…
By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA…
The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without…